Pergolide (marketed as Permax) Information
FDA today announces that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves.
Public Health Advisory - Pergolide (marketed as Permax)
FDA Announces Voluntary Withdrawal of Pergolide Products[ARCHIVED]
FDA press release (3/29/2007)